Peanuts Second Meal Glycemic Response
Launched by FEDERAL UNIVERSITY OF VICOSA · Aug 8, 2011
Trial Information
Current as of September 04, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Body mass index between 30 - 35 kg/M2
- • Not taking medications known to affect glycemia, fat metabolism, or appetite
- • Regular breakfast consumer (≥100 kilocalories ingested within 2 hours of waking on ≥4d/wk)
- • No body weight fluctuation (\<5kg in the past 3 months)
- • Willingness to eat all test foods
- • No self-reported allergy to the foods provided in the study
- • No self-reported sleep disorders
- • At least one of the following conditions: waist circumference ≥ 88 cm; reported family history of Type 2 diabetes in first degree relatives; capillary glycemia between 5.5 - 7.0 mmol/L; and/or a 2-hour blood glucose of 7.8 - 11.1 mmol/L (impaired glucose tolerance)
- Exclusion Criteria:
- • Type 2 diabetes mellitus
- • Dyslipidemia
- • High blood pressure
About Federal University Of Vicosa
The Federal University of Viçosa (Universidade Federal de Viçosa - UFV) is a prominent Brazilian institution dedicated to advancing education, research, and innovation in the fields of agricultural sciences, health, and environmental sustainability. With a strong emphasis on interdisciplinary collaboration, UFV actively engages in clinical trials that aim to enhance public health outcomes and contribute to the scientific community. The university's commitment to ethical research practices and adherence to regulatory standards ensures the integrity and reliability of its clinical studies, making it a trusted sponsor in the advancement of medical knowledge and patient care.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Viçosa, Minas Gerais, Brazil
Patients applied
Trial Officials
Caio EG Reis, PhD Student
Principal Investigator
University of Brasília, Brazil
Daniela N Ribeiro, M.Sc.
Study Chair
Federal University of Viçosa, Brazil
Neuza MB Costa, Ph.D.
Study Chair
Federal University of Espírito Santo, Brazil
Josefina Bressan, Ph.D.
Study Chair
Federal University of Viçosa, Brazil
Rita CG Alfenas, Ph.D.
Principal Investigator
Federal University of Viçosa, Brazil
Richard D Mattes, Ph.D.
Study Director
Purdue University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials